Practice Effects and Stability of Neuropsychological and UHDRS Tests over Short Retest Intervals in Huntington Disease

Leigh J. Beglinger, William H. Adams, Jess G. Fiedorowicz, Kevin Duff, Douglas Langbehn, Kevin Biglan, John Nathaniel Caviness, Blair Olson, Jane S. Paulsen

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: In Huntington disease (HD), cognitive changes due to disease-progression or treatment are potentially confounded by "practice effects" (PE) - performance improvement from prior exposure to test materials. Objective: A practice run-in ("dual baseline") was used in an HD cognitive trial to determine if PE could be minimized and evaluate performance trajectories over multiple visits. Methods: Non-depressed adults (N= 36) with mild to moderate HD-related cognitive deficits participated in a clinical trial to examine the efficacy of citalopram to enhance cognition. Cognitive tests were administered at three visits (2 weeks separating each visit), before active treatment randomization. Some tests were also administered at screening. Therefore 3-4 pre-treatment repetitions were available. We examined test improvement using repeated-measures ANOVAs with planned pairwise comparisons. Results: Despite the practice run-in and use of alternate test forms, results indicated ongoing improvements over at least three test sessions on all three UHDRS cognitive tests. Trails A and B showed improvements between the third and fourth session, which suggests that one pre-baseline visit may not be effective in reducing practice on this important and commonly used test. Conclusions: Overall, 7 out of 13 variables showed some degree of short-term PE, even after multiple sessions and alternate forms. Tests assessing processing speed and memory may be particularly confounded by ongoing PE across at least 2-3 sessions. Practice run-in periods and alternate forms may help minimize the impact of such effects in HD clinical trials but awareness of which tests are most susceptible to PE is important in clinical trial design.

Original languageEnglish (US)
Pages (from-to)251-260
Number of pages10
JournalJournal of Huntington's disease
Volume4
Issue number3
DOIs
StatePublished - Sep 29 2015

Fingerprint

Neuropsychological Tests
Huntington Disease
Clinical Trials
Practice (Psychology)
Citalopram
Random Allocation
Cognition
Disease Progression
Analysis of Variance

Keywords

  • cognitive disorders/dementia
  • Huntington disease
  • neuropsychological assessment
  • practice effects

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

Beglinger, L. J., Adams, W. H., Fiedorowicz, J. G., Duff, K., Langbehn, D., Biglan, K., ... Paulsen, J. S. (2015). Practice Effects and Stability of Neuropsychological and UHDRS Tests over Short Retest Intervals in Huntington Disease. Journal of Huntington's disease, 4(3), 251-260. https://doi.org/10.3233/JHD-150159

Practice Effects and Stability of Neuropsychological and UHDRS Tests over Short Retest Intervals in Huntington Disease. / Beglinger, Leigh J.; Adams, William H.; Fiedorowicz, Jess G.; Duff, Kevin; Langbehn, Douglas; Biglan, Kevin; Caviness, John Nathaniel; Olson, Blair; Paulsen, Jane S.

In: Journal of Huntington's disease, Vol. 4, No. 3, 29.09.2015, p. 251-260.

Research output: Contribution to journalArticle

Beglinger, LJ, Adams, WH, Fiedorowicz, JG, Duff, K, Langbehn, D, Biglan, K, Caviness, JN, Olson, B & Paulsen, JS 2015, 'Practice Effects and Stability of Neuropsychological and UHDRS Tests over Short Retest Intervals in Huntington Disease', Journal of Huntington's disease, vol. 4, no. 3, pp. 251-260. https://doi.org/10.3233/JHD-150159
Beglinger, Leigh J. ; Adams, William H. ; Fiedorowicz, Jess G. ; Duff, Kevin ; Langbehn, Douglas ; Biglan, Kevin ; Caviness, John Nathaniel ; Olson, Blair ; Paulsen, Jane S. / Practice Effects and Stability of Neuropsychological and UHDRS Tests over Short Retest Intervals in Huntington Disease. In: Journal of Huntington's disease. 2015 ; Vol. 4, No. 3. pp. 251-260.
@article{8c6b68d27f9845fea7f36cae1b14624e,
title = "Practice Effects and Stability of Neuropsychological and UHDRS Tests over Short Retest Intervals in Huntington Disease",
abstract = "Background: In Huntington disease (HD), cognitive changes due to disease-progression or treatment are potentially confounded by {"}practice effects{"} (PE) - performance improvement from prior exposure to test materials. Objective: A practice run-in ({"}dual baseline{"}) was used in an HD cognitive trial to determine if PE could be minimized and evaluate performance trajectories over multiple visits. Methods: Non-depressed adults (N= 36) with mild to moderate HD-related cognitive deficits participated in a clinical trial to examine the efficacy of citalopram to enhance cognition. Cognitive tests were administered at three visits (2 weeks separating each visit), before active treatment randomization. Some tests were also administered at screening. Therefore 3-4 pre-treatment repetitions were available. We examined test improvement using repeated-measures ANOVAs with planned pairwise comparisons. Results: Despite the practice run-in and use of alternate test forms, results indicated ongoing improvements over at least three test sessions on all three UHDRS cognitive tests. Trails A and B showed improvements between the third and fourth session, which suggests that one pre-baseline visit may not be effective in reducing practice on this important and commonly used test. Conclusions: Overall, 7 out of 13 variables showed some degree of short-term PE, even after multiple sessions and alternate forms. Tests assessing processing speed and memory may be particularly confounded by ongoing PE across at least 2-3 sessions. Practice run-in periods and alternate forms may help minimize the impact of such effects in HD clinical trials but awareness of which tests are most susceptible to PE is important in clinical trial design.",
keywords = "cognitive disorders/dementia, Huntington disease, neuropsychological assessment, practice effects",
author = "Beglinger, {Leigh J.} and Adams, {William H.} and Fiedorowicz, {Jess G.} and Kevin Duff and Douglas Langbehn and Kevin Biglan and Caviness, {John Nathaniel} and Blair Olson and Paulsen, {Jane S.}",
year = "2015",
month = "9",
day = "29",
doi = "10.3233/JHD-150159",
language = "English (US)",
volume = "4",
pages = "251--260",
journal = "Journal of Huntington's disease",
issn = "1879-6397",
publisher = "IOS Press",
number = "3",

}

TY - JOUR

T1 - Practice Effects and Stability of Neuropsychological and UHDRS Tests over Short Retest Intervals in Huntington Disease

AU - Beglinger, Leigh J.

AU - Adams, William H.

AU - Fiedorowicz, Jess G.

AU - Duff, Kevin

AU - Langbehn, Douglas

AU - Biglan, Kevin

AU - Caviness, John Nathaniel

AU - Olson, Blair

AU - Paulsen, Jane S.

PY - 2015/9/29

Y1 - 2015/9/29

N2 - Background: In Huntington disease (HD), cognitive changes due to disease-progression or treatment are potentially confounded by "practice effects" (PE) - performance improvement from prior exposure to test materials. Objective: A practice run-in ("dual baseline") was used in an HD cognitive trial to determine if PE could be minimized and evaluate performance trajectories over multiple visits. Methods: Non-depressed adults (N= 36) with mild to moderate HD-related cognitive deficits participated in a clinical trial to examine the efficacy of citalopram to enhance cognition. Cognitive tests were administered at three visits (2 weeks separating each visit), before active treatment randomization. Some tests were also administered at screening. Therefore 3-4 pre-treatment repetitions were available. We examined test improvement using repeated-measures ANOVAs with planned pairwise comparisons. Results: Despite the practice run-in and use of alternate test forms, results indicated ongoing improvements over at least three test sessions on all three UHDRS cognitive tests. Trails A and B showed improvements between the third and fourth session, which suggests that one pre-baseline visit may not be effective in reducing practice on this important and commonly used test. Conclusions: Overall, 7 out of 13 variables showed some degree of short-term PE, even after multiple sessions and alternate forms. Tests assessing processing speed and memory may be particularly confounded by ongoing PE across at least 2-3 sessions. Practice run-in periods and alternate forms may help minimize the impact of such effects in HD clinical trials but awareness of which tests are most susceptible to PE is important in clinical trial design.

AB - Background: In Huntington disease (HD), cognitive changes due to disease-progression or treatment are potentially confounded by "practice effects" (PE) - performance improvement from prior exposure to test materials. Objective: A practice run-in ("dual baseline") was used in an HD cognitive trial to determine if PE could be minimized and evaluate performance trajectories over multiple visits. Methods: Non-depressed adults (N= 36) with mild to moderate HD-related cognitive deficits participated in a clinical trial to examine the efficacy of citalopram to enhance cognition. Cognitive tests were administered at three visits (2 weeks separating each visit), before active treatment randomization. Some tests were also administered at screening. Therefore 3-4 pre-treatment repetitions were available. We examined test improvement using repeated-measures ANOVAs with planned pairwise comparisons. Results: Despite the practice run-in and use of alternate test forms, results indicated ongoing improvements over at least three test sessions on all three UHDRS cognitive tests. Trails A and B showed improvements between the third and fourth session, which suggests that one pre-baseline visit may not be effective in reducing practice on this important and commonly used test. Conclusions: Overall, 7 out of 13 variables showed some degree of short-term PE, even after multiple sessions and alternate forms. Tests assessing processing speed and memory may be particularly confounded by ongoing PE across at least 2-3 sessions. Practice run-in periods and alternate forms may help minimize the impact of such effects in HD clinical trials but awareness of which tests are most susceptible to PE is important in clinical trial design.

KW - cognitive disorders/dementia

KW - Huntington disease

KW - neuropsychological assessment

KW - practice effects

UR - http://www.scopus.com/inward/record.url?scp=84961711406&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961711406&partnerID=8YFLogxK

U2 - 10.3233/JHD-150159

DO - 10.3233/JHD-150159

M3 - Article

C2 - 26444022

AN - SCOPUS:84961711406

VL - 4

SP - 251

EP - 260

JO - Journal of Huntington's disease

JF - Journal of Huntington's disease

SN - 1879-6397

IS - 3

ER -